Mohamad Makhzoumi, 10% Owner at Regulus Therapeutics Inc. (RGLS), bought 8,797,204 shares at $0.62 ($5.5M) on 2020-12-04, disclosed to the SEC on 2020-12-07.
Open-market purchase of $5.5M RGLS by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.62 | 4,398,602 | $2.7M | 50.0% |
| 2 | $0.62 | 4,398,602 | $2.7M | 50.0% |
| Total | $0.62 avg | 8,797,204 | $5.5M | 100% |
| Filing → |
| MBX | BUY | 2024-09-17 | $8.0M | — | Filing → |
| KRRO | BUY | 2024-04-24 | $1000K | — | Filing → |
| SVRA | BUY | 2023-07-19 | $1000K | — | Filing → |